Adverse events288

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 288

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	76	141	208
other	Anaemia	Blood and lymphatic system disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	36	70	121
other	Neutropenia	Blood and lymphatic system disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	55	141	225
other	Neutropenia	Blood and lymphatic system disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	24	70	82
other	Leukopenia	Blood and lymphatic system disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	21	141	74
other	Leukopenia	Blood and lymphatic system disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	7	70	20
other	Thrombocytopenia	Blood and lymphatic system disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	42	141	109
other	Thrombocytopenia	Blood and lymphatic system disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	19	70	86
other	Abdominal discomfort	Gastrointestinal disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	9	141	14
other	Abdominal discomfort	Gastrointestinal disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	9	70	11
other	Abdominal distension	Gastrointestinal disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	9	141	12
other	Abdominal distension	Gastrointestinal disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	4	70	5
other	Abdominal pain	Gastrointestinal disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	39	141	65
other	Abdominal pain	Gastrointestinal disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	22	70	34
other	Abdominal pain upper	Gastrointestinal disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	17	141	19
other	Abdominal pain upper	Gastrointestinal disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	12	70	17
other	Constipation	Gastrointestinal disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	58	141	93
other	Constipation	Gastrointestinal disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	31	70	53
other	Diarrhoea	Gastrointestinal disorders	Farletuzumab 5 mg/kg + Carboplatin/Paclitaxel or Carboplatin/PLD	48	141	83
other	Diarrhoea	Gastrointestinal disorders	Placebo + Carboplatin/Paclitaxel or Carboplatin/PLD	27	70	63

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02289950/events

API reference For AI assistants

Adverse events288

Sources 3

Read this list from software.